Search clinical trials for: Drug: Placebo

Total 268254 results

Vakzine Projekt Management GmbH
FGK Clinical Research GmbH

Unknown

Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic

Infection, Respiratory Tract

Germany
Tufts Medical Center

Terminated

Renal AL Amyloid Involvement and NEOD001 (RAIN)

Amyloidosis

United States
Astellas Pharma Inc
Immunomic Therapeutics, Inc.

Completed

A Dose-finding Study of ASP4070

Rhinitis, Allergic, Seasonal

Japan
Hadassah Medical Organization
Sheba Medical Center; Wolfson Medical Center

Unknown

The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation

Covid19 Pneumonia

Israel
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer (PREVAIL)

Prostate Cancer

Canada, United States, Spain, Australia, Denmark, Korea, Republic of, Belgium, Singapore, Finland, Netherlands, France, Austria, Germany, Israel, United Kingdom, Italy, Japan, Lithuania, Poland, Russian Federation, Slovakia, Sweden
MedImmune LLC
National Institute of Allergy and Infectious Diseases (NIAID); Innovative Medicines... and other collaborators

Completed

Study of the Efficacy and Safety of MEDI4893 (SAATELLITE)

Staphylococcus Aureus Pneumonia

Spain, Belgium, United States, France, Germany, Czechia, Greece, Switzerland, Hungary, Portugal
Wanwarang Wongcharoen, MD.

Completed

Effects of CUrcuminoids on Coronary Artery byPass graftIng-related myocarDial Infarction Study (CUPID)

Coronary Artery Bypass Grafting

Thailand
Takeda
National Institutes of Health (NIH)

Completed

Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector

Healthy Volunteers

United States
Merck Sharp & Dohme LLC
National Institute of Allergy and Infectious Diseases (NIAID); BioProtection...

Completed

Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002)

Ebola Viruses
Merck Sharp & Dohme LLC

Completed

A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)

Herpes Zoster | Herpes Zoster-related Complications
Astellas Pharma Global Development, Inc.
Vical

Completed

An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients

Healthy Subjects | Cytomegalovirus Infection | Dialysis

United States
Institute of Virology, Vaccines and Sera, Torlak
PATH; World Health Organization; Comac Medical

Completed

Phase 3 Trial of Serbian Seasonal Influenza Vaccine (Torlak-300)

Influenza

Serbia
Seqirus
Biomedical Advanced Research and Development Authority

Completed

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

Avian Influenza

United States
Hospital Civil de Guadalajara

Completed

Supplementation of Thyroid Hormone for TSH Control in Patients With Chronic Kidney Disease Without TRR. (TSHrenal)

Chronic Kidney Diseases | Subclinical Hypothyroidism

Mexico
Implicit Bioscience

Withdrawn

IC14 in Adult Patients With Dengue Fever

Dengue Fever
Faes Farma, S.A.
Allied Research International

Completed

PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)

Seasonal Allergic Rhinitis | Hay Fever | Rhinoconjunctivitis

Canada
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease (ALBUM)

Type 2 Diabetes | Chronic Kidney Disease

Spain, Czechia, Denmark, Germany, Hungary, Italy, Netherlands, Poland, United Kingdom
AstraZeneca
Parexel

Completed

Multiple-ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Healthy Male Subjects

Healthy Volunteers

United Kingdom
GlaxoSmithKline

Completed

A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.

Infections, Rotavirus

Dominican Republic
GlaxoSmithKline

Completed

Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD

Pulmonary Disease, Chronic Obstructive

Germany, Japan, United States
Qu Biologics Inc.

Withdrawn

Single and Multiple Dose Evaluation of QBKPN SSI In Healthy Volunteers

Healthy
GlaxoSmithKline

Completed

P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain

Pain, Neuropathic

Germany, Russian Federation, Australia, United Kingdom
GlaxoSmithKline

Completed

Investigation Of a New Oral Anti-Histamine in Healthy Male Subjects

Rhinitis, Allergic, Seasonal

United Kingdom
GlaxoSmithKline

Completed

A Phase I Rheumatoid Arthritis Study in Healthy Volunteers

Arthritis, Rheumatoid

United States
GlaxoSmithKline

Completed

Anti-MAG First Administration to Human

Cerebrovascular Accident

United States, Australia
GlaxoSmithKline

Terminated

Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia

Telangiectasia, Hereditary Hemorrhagic

United States, Canada
Massachusetts General Hospital
National Institute on Drug Abuse (NIDA); GlaxoSmithKline; Mclean Hospital

Completed

Effectiveness of GSK598809, a Selective D3 Antagonist, Added to CBT and NRT for Smoking Cessation and Relapse Prevention

Nicotine Dependence

United States
GlaxoSmithKline

Completed

Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis

Arthritis, Rheumatoid

Ukraine, Russian Federation, New Zealand, Australia, Serbia
GlaxoSmithKline

Completed

Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women

Infections, Papillomavirus
University Hospital, Basel, Switzerland

Completed

Trust Game and Placebo Response

Pain | Placebo Effect | Trust

Switzerland
AstraZeneca
MedImmune Ltd

Completed

Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis

Ulcerative Colitis

Italy, Poland, United Kingdom, France, Czech Republic, Germany
Covagen

Terminated

Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis

Plaque Psoriasis

Germany
Novartis Pharmaceuticals

Completed

Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis

Ankylosing Spondylitis

United States, Germany, Netherlands, United Kingdom
Pierre Fabre Medicament

Completed

Assessment of V0018 2.5 mg Effect on Craving

Healthy Highly Dependant Smokers

France
Medical Centre Leeuwarden

Completed

Hydrochloorthiazide and Hypernatriaemie

Hypernatraemia

Netherlands
Nora Therapeutics, Inc.

Completed

A Multi-Center Study To Evaluate Multiple Doses of NT100 Following IVF In Women With Repeated IVF Failures (Thrive-IVF) (Thrive-IVF)

Repeated IVF Failure

United States
Federico II University

Completed

Effects of Somatostatin on ADPKD Heart

Autosomal Dominant Polycystic Kidney Disease | Glomerular Filtration Rate > 40 ml/Min
University Hospital, Angers

Unknown

Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)

Huntington's Disease

France
Revance Therapeutics, Inc.

Completed

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Lateral Canthal Lines

United States
AVIR Green Hills Biotechnology AG

Completed

Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults

Influenza, Human

Austria
Rockefeller University

Completed

Analysis of Diphenylcyclopropenone (DPCP) in Normals

Healthy Volunteers

United States
Apeiron Biologics

Completed

Study of APN201 (Liposomal Recombinant Human Cu/Zn-Superoxide Dismutase) for the Prevention of Radiation-induced Dermatitis in Women With Breast Cancer

Radiation Induced Dermatitis

Austria
Astellas Pharma Inc

Completed

Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

United Kingdom, Belgium, Spain, Netherlands, Ireland, Hungary
Hoffmann-La Roche

Completed

A Single-Ascending-Dose Study of RO5469754 in Healthy Volunteers

Healthy Volunteer

Netherlands
Genentech, Inc.

Completed

A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers

Foot Ulcer, Diabetic
AlphaVax, Inc.

Completed

A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza (AVX502-003)

Influenza

United States
CeNeRx BioPharma Inc.

Completed

Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers (CX157-112)

Major Depressive Disorder

United States
Pantarhei Bioscience

Completed

Preoperative Estetrol in Breast Cancer

Breast Cancer

Austria
Trio Medicines Ltd.
James Black Foundation

Completed

Effect of Repeated Doses of YF476 on Stomach Acidity

Hypergastrinaemia

United Kingdom
Institut National de la Santé Et de la Recherche...
European Union; Swedish Institute for Infectious Disease Control; Innogenetics

Completed

First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine

Pertussis

Sweden

Search clinical trials for: Drug: Placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations